Cipher Pharmaceuticals
ON - Mississauga
Pharmaceutical1 H-1B visas (FY2023)Focus: Small Molecules
Cipher Pharmaceuticals is a life sciences company focused on Small Molecules.
Neurology
Funding Stage
PUBLIC
Open Jobs
0
Products & Portfolio (3)
2 discontinued products not shown
NATROBA
spinosad
Peak
TOPICAL · SUSPENSION
insects. After periods of hyperexcitation, lice and mites become paralyzed and die.
2011
0
QINLOCK
ripretinib
Peak
SMORAL · TABLET
Stem Cell Factor (KIT) Receptor Inhibitors
2020
0
ROMVIMZA
vimseltinib
Growth
SMORAL · CAPSULE
Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors
2025
0
Pipeline & Clinical Trials
PEBRA model
HIV/AIDSClinical Trials (1)
NCT03969030Peer-Educator-coordinated vs Nurse-coordinated ART Refill for Adolescents and Young Adults Living With HIV in Lesotho
N/ATramadol HCl
HealthyTramadol HCl, 50 mg
HealthyCIP-Isotretinoin
Severe Nodular AcneClinical Trials (1)
NCT00975143Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne
Phase 3Spinosad Topical
ScabiesClinical Trials (1)
NCT05310734PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With Scabies
Phase 4Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 5 approved products, 3 clinical trials
Top TAs: Oncology, Cardiovascular, Infectious Diseases
H-1B (2023): 1 approval
Portfolio Health
Growth1 (20%)
Peak2 (40%)
LOE Approaching2 (40%)
5 total products
Therapeutic Area Focus
Marketed
Pipeline
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub